Related Funds
Fund Name | Location |
Automattic | California, San Francisco, United States |
Elevation Capital | Australia, New South Wales, Sydney |
EMPA | Dubendorf, Switzerland, Zurich |
Five Point Energy | Texas, The Woodlands, United States |
Grit Ventures | Canada, Mississauga, Ontario |
International Technology Solutions | Luxembourg, Luxembourg |
Las Olas Venture Capital (LOVC) | Florida, Fort Lauderdale, United States |
RBC Ventures | Canada, Ontario, Toronto |
Tongdun Technology | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Paques Biomaterials | $16M | 27 Jan 2024 | The Netherlands, Flevoland, Netherlands | ||
Onera Health | $35M | 16 Jan 2024 | Palo Alto, California, United States | ||
SCIL Nanoimprint solutions | $11M | 12 Dec 2023 | Eindhoven, Noord-Brabant, The Netherlands | ||
Microsure | $44M | 19 Sep 2023 | Eindhoven, North Brabant, Netherlands | ||
Meatable | $36M | 07 Aug 2023 | Delft, South Holland, Netherlands | ||
E-magy | $17M | 19 Apr 2023 | The Netherlands, North Holland, Netherlands | ||
BYBORRE | $19M | 06 Feb 2023 | Amsterdam, Noord-Holland, The Netherlands | ||
SALDTech | $6M | 15 Nov 2022 | - | ||
Elestor | $35M | 30 Aug 2022 | Arnhem, Gelderland, The Netherlands |
– Onera closed the Series B funding round, which brought the total funding raised to date above the €24M mark.
– Innovation Industries led the round in collaboration with Invest-NL and with existing investors Jazz Pharmaceuticals, imec.xpand, BOM and 15th Rock.
– The company intends to use the funds to execute clinical studies and further commercialize its sleep diagnostics and monitoring products in Europe and the United States.
– Onera recently relocated its headquarters to the Brainport region in Eindhoven, the Netherlands, while maintaining commercial operations in the United States.
– ISA Pharmaceuticals B.V. from Oegstgeest, The Netherlands closed a €26m funding round.
– Backers included new investor – Invest-NL and existing investors including Regeneron.
– The company intends to use the funds to advance the lead product ISA101b towards first marketing authorization as well as to broaden the clinical pipeline of immunotherapies based on the Synthetic Long Peptide (SLP®) platform technology.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Paques Biomaterials | $16M | 27 Jan 2024 | The Netherlands, Flevoland, Netherlands | ||
Onera Health | $35M | 16 Jan 2024 | Palo Alto, California, United States | ||
SCIL Nanoimprint solutions | $11M | 12 Dec 2023 | Eindhoven, Noord-Brabant, The Netherlands | ||
Microsure | $44M | 19 Sep 2023 | Eindhoven, North Brabant, Netherlands | ||
Meatable | $36M | 07 Aug 2023 | Delft, South Holland, Netherlands | ||
E-magy | $17M | 19 Apr 2023 | The Netherlands, North Holland, Netherlands | ||
BYBORRE | $19M | 06 Feb 2023 | Amsterdam, Noord-Holland, The Netherlands | ||
SALDTech | $6M | 15 Nov 2022 | - | ||
Elestor | $35M | 30 Aug 2022 | Arnhem, Gelderland, The Netherlands |